Cytosorbents Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CTSO Nasdaq 3841 www.cytosorbents.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytosorbents Corporation

Q1 2025 Cytosorbents Corp Earnings Call - May 15th, 2025 12:58 pm
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - May 15th, 2025 7:16 am
CytoSorbents: Q1 Earnings Snapshot - May 14th, 2025 8:50 pm
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update - May 14th, 2025 8:01 pm
CTSO: CytoSorbents provides regulatory update for DrugSorb-ATR. - May 8th, 2025 2:04 pm
CytoSorbents Provides Regulatory Update for DrugSorb-ATR - May 1st, 2025 8:15 pm
CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights - Apr 29th, 2025 11:00 am
CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program - Apr 21st, 2025 11:00 am
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - Apr 17th, 2025 11:00 am
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America - Apr 14th, 2025 11:00 am
CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants - Apr 4th, 2025 11:00 am
CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. - Apr 4th, 2025 9:16 am
Q4 2024 Cytosorbents Corp Earnings Call - Apr 1st, 2025 10:44 am
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Apr 1st, 2025 7:04 am
CytoSorbents: Q4 Earnings Snapshot - Mar 31st, 2025 8:59 pm
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - Mar 31st, 2025 8:15 pm
CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - Mar 21st, 2025 11:00 am
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago - Mar 10th, 2025 12:06 pm
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller - Mar 4th, 2025 12:00 pm
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - Feb 26th, 2025 12:00 pm